News
DEA Proposes Reduction in Manufacturing of Opioids for 2018
The DEA has proposed to reduce the manufacturing of controlled substances in the United States…
ASIA Summer Conference
Tami Bell, Account Executive, will be at booth #25 in Destin for the ASIA Summer…
Launch of Generic Relpax
The generic equivalent of Relpax (Eletriptan) has just been released, following FDA approval. Relpax is…
Louisiana Enacts New Laws Regarding Opioid Prescribing Limits
Louisiana joined several states in enacting new laws limiting the days’ supply of a new…
2017 LASIE Open Forum
John Means, Regional Sales Manager, will be attending the 2017 LASIE Open Forum. He will…
Excellence in Caring: Lauren
Lauren has been with the Retail Department at Carlisle Medical for nearly eight months. She…
Endo Pharmaceuticals, Inc. Announces Withdrawal of Opana ER
Endo Pharmaceuticals announced it would be voluntarily withdrawing Opana ER (Oxymorphone ER) from the market….
Excellence in Caring: Denise
I would like to nominate Denise. She was in charge of my DME training. She…
42nd Annual Florida RIMS Educational Conference
Dean Moroney, Account Executive, will be attending the 42nd Annual Florida RIMS Educational Conference July…
Ohio Self Insured Conference
Our National Sales Executive, Dunn Swanson, will be attending the Ohio Self Insured Conference June…
